Reese J, Zervos T, Rock J, Tabbarah A, Noushmehr H, Herrgott G
Arch Endocrinol Metab. 2025; 68(Spec Issue):e230506.
PMID: 39876960
PMC: 11771751.
DOI: 10.20945/2359-4292-2023-0506.
Mohseni S, Mirdamadi N, Mossavarali S, Mohajeri-Tehrani M, Pejman Sani M
J Diabetes Metab Disord. 2024; 23(2):2143-2149.
PMID: 39610525
PMC: 11599527.
DOI: 10.1007/s40200-024-01481-9.
Lopes-Pinto M, Lacerda-Nobre E, Silva A, Marques P
Cancers (Basel). 2024; 16(17).
PMID: 39272895
PMC: 11394371.
DOI: 10.3390/cancers16173033.
Tsai Y, Li C, Wang Y, Chen S
Medicina (Kaunas). 2024; 60(8).
PMID: 39202626
PMC: 11356365.
DOI: 10.3390/medicina60081345.
Sahakian N, Goetz L, Appay R, Graillon T, Raingeard I, Piazzola C
Pituitary. 2024; 27(5):644-653.
PMID: 38995473
DOI: 10.1007/s11102-024-01428-6.
Germline Variants in Sporadic Pituitary Adenomas.
Alzahrani A, Bin Nafisah A, Alswailem M, Alghamdi B, Alsaihati B, Aljafar H
J Endocr Soc. 2024; 8(6):bvae085.
PMID: 38745824
PMC: 11091836.
DOI: 10.1210/jendso/bvae085.
Pituitary Adenoma Prevalence and Characteristics of Omani Patients: A Single Center Experience.
Al Futaisi A, Al Marzouqi A, Al Abri M, Al Riyami M
Oman Med J. 2024; 39(1):e589.
PMID: 38567166
PMC: 10985075.
DOI: 10.5001/omj.2024.44.
induces -mediated autophagy to exert anti-metastatic effects in pituitary adenomas.
Qiu C, Yao Y, Hu S, Xu Y
Transl Cancer Res. 2024; 13(2):661-675.
PMID: 38482414
PMC: 10928634.
DOI: 10.21037/tcr-23-1320.
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline pathogenic variant in the absence of paraganglioma or pheochromocytoma.
Alzahrani A, Bin Nafisah A, Alswailem M, Moria Y, Poprawski D, Al-Hindi H
Front Endocrinol (Lausanne). 2023; 14:1273093.
PMID: 38152133
PMC: 10751293.
DOI: 10.3389/fendo.2023.1273093.
Microvascular Changes in Pituitary Adenoma Correlate with Structural Measurements and Visual Field Loss.
Chen Y, Li X, Song X, Cong L, Zhang Y
Neuropsychiatr Dis Treat. 2023; 19:2745-2754.
PMID: 38090020
PMC: 10710949.
DOI: 10.2147/NDT.S425454.
Research progress on the role of the Wnt signaling pathway in pituitary adenoma.
Wang W, Ma L, Zhao Y, Liu M, Ye W, Li X
Front Endocrinol (Lausanne). 2023; 14:1216817.
PMID: 37780610
PMC: 10538627.
DOI: 10.3389/fendo.2023.1216817.
Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?.
Pekic S, Stojanovic M, Popovic V
Endocr Oncol. 2023; 2(1):R1-R13.
PMID: 37435457
PMC: 10259320.
DOI: 10.1530/EO-21-0033.
Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone.
Barlas T, Yalcin M, Avci D, Kaplan Y, Akturk M, Balos Toruner F
Pituitary. 2023; 26(4):411-418.
PMID: 37261656
DOI: 10.1007/s11102-023-01328-1.
Upregulation of MAPKAPK5-AS1, PXN-AS1 and URB1-AS1 lncRNAs in non-functioning pituitary adenoma.
Taheri M, Safarzadeh A, Bahranian A, Eslami S, Dilmaghani N, Ghafouri-Fard S
J Cell Mol Med. 2023; 27(11):1550-1556.
PMID: 37154079
PMC: 10243150.
DOI: 10.1111/jcmm.17763.
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment.
de Figueiredo R, de Souza Junior J, Triarca P, Beer-Furlan A, Melo N, Fernandes de Oliveira Santos B
Pituitary. 2023; 26(4):383-392.
PMID: 37115292
DOI: 10.1007/s11102-023-01317-4.
Functioning gonadotroph adenoma with hyperestrogenemia and ovarian hyperstimulation in a reproductive-aged woman: A case report and review of literature.
He Y, Gao Y, Sun L
World J Clin Cases. 2023; 11(6):1341-1348.
PMID: 36926127
PMC: 10013118.
DOI: 10.12998/wjcc.v11.i6.1341.
Prolactinomas in adolescent and elderly patients-A comparative long-term analysis.
Andereggen L, Tortora A, Schubert G, Musahl C, Frey J, Luedi M
Front Surg. 2023; 10:967407.
PMID: 36814862
PMC: 9939754.
DOI: 10.3389/fsurg.2023.967407.
Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.
Iglesias P, Biagetti B, Araujo-Castro M, Alcazar V, Guerrero-Perez F, Rivero N
J Neurooncol. 2022; 160(2):351-359.
PMID: 36355257
DOI: 10.1007/s11060-022-04149-7.
Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma.
Raghib M, Salim A, Angez M, Ghazi S, Hashmi S, Tariq M
J Neurooncol. 2022; 160(2):491-496.
PMID: 36315367
DOI: 10.1007/s11060-022-04168-4.
Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics.
Wang X, Li M, Jiang X, Wang F, Ling S, Niu C
Brain Sci. 2022; 12(8).
PMID: 36009065
PMC: 9405805.
DOI: 10.3390/brainsci12081002.